The tumours of Pten deleted mice matched with the molecular features of luminal A and non-BRCA1/2 cancers, whereas Brca2:p53/Pten:p53 gene signature had been seen across the range of human breast cancer molecular subtypes. This evidence concerns the gene BRCA2 and breast carcinoma.